Related Experiment Video
Updated: Jul 13, 2026
10:10
Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
Shoulder Arthroplasty in Hemophilia
E Carlos Rodriguez-Merchan1, Hortensia De la Corte-Rodriguez2, Samuel Antuña1
1Department of Orthopedic Surgery, La Paz University Hospital, Madrid, Spain.
The Archives of Bone and Joint Surgery
|March 28, 2025
Summary
Shoulder arthroplasty shows promising implant survival in people with hemophilia (PWH), comparable to controls. Careful management of bleeding risks and blood clot prevention is crucial for successful outcomes.
Area of Science:
- Orthopedic Surgery
- Hematology
- Arthroplasty
Background:
- Hemophilia presents unique challenges for surgical procedures.
- Shoulder arthroplasty is a potential treatment for shoulder joint issues in PWH.
Purpose of the Study:
- To review the current literature on shoulder arthroplasty outcomes in people with hemophilia (PWH).
- To assess the safety and efficacy of total shoulder arthroplasty (TSA) in PWH.
Main Methods:
- Literature search conducted in PubMed using keywords 'hemophilia' and 'shoulder arthroplasty'.
- Analysis of 4 published articles reporting on 84 shoulder arthroplasties in PWH.
Main Results:
- Five-year implant survival in PWH (97.3%) was similar to matched controls (95.2%).
- High risks of postoperative bleeding complications and venous thromboembolism (VTE) were noted in PWH.
Conclusions:
- Total shoulder arthroplasty (TSA) demonstrates lasting survivorship and may be a viable option for PWH.
- Meticulous, individualized perioperative management of factor replacement and VTE prophylaxis, with hematologist collaboration, is essential for PWH undergoing TSA.
